SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?

To: oilbabe who wrote (86435)12/13/1999 10:38:00 PM
From: Harold Engstrom  Read Replies (1) | Respond to of 164684
 
oilbabe, I owned Genzyme for several years and until I sold a couple of years ago, they always missed their estimates. This was nearly always because of extraordinary changes (they had some every quarter). I bought back again during recent weakness and think they have great promise. It is time for Genzyme to start delivering on that promise and I think they can do it (even if they keep special charging!).



To: oilbabe who wrote (86435)12/14/1999 12:17:00 AM
From: Derrick P.  Respond to of 164684
 
If your looking at Genz, check out their tracking stocks Gzmo and Gztc. They seem to be the cutting (bleeding?) edge technology groups for Genz.
Also in the biotech sector; Vphm is working on cures for viral infections like the common cold and Hepatitis C.
dailynews.yahoo.com
biz.yahoo.com

Also it looks like it is about to break out to a new high.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News